PDB Short entry for 4DBN HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-JAN-12 4DBN TITLE CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN B-RAF WITH A [1, TITLE 2 3]THIAZOLO[5,4-B]PYRIDINE DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE B-RAF; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 445-726); COMPND 5 SYNONYM: PROTO-ONCOGENE B-RAF, P94, V-RAF MURINE SARCOMA VIRAL COMPND 6 ONCOGENE HOMOLOG B1; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRAF, BRAF1, P94, RAFB1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFASTBAC KEYWDS KINASE DRUG COMPLEX, SER/THR KINASE, ATP BINDING, PHOSPHORYLATION, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.K.YANO,K.AERTGEERTS REVDAT 3 28-FEB-24 4DBN 1 REMARK SEQADV REVDAT 2 13-JUN-12 4DBN 1 JRNL REVDAT 1 11-APR-12 4DBN 0 JRNL AUTH M.OKANIWA,M.HIROSE,T.IMADA,T.OHASHI,Y.HAYASHI,T.MIYAZAKI, JRNL AUTH 2 T.ARITA,M.YABUKI,K.KAKOI,J.KATO,T.TAKAGI,T.KAWAMOTO,S.YAO, JRNL AUTH 3 A.SUMITA,S.TSUTSUMI,T.TOTTORI,H.OKI,B.C.SANG,J.YANO, JRNL AUTH 4 K.AERTGEERTS,S.YOSHIDA,T.ISHIKAWA JRNL TITL DESIGN AND SYNTHESIS OF NOVEL DFG-OUT RAF/VASCULAR JRNL TITL 2 ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 (VEGFR2) INHIBITORS. 1. JRNL TITL 3 EXPLORATION OF [5,6]-FUSED BICYCLIC SCAFFOLDS. JRNL REF J.MED.CHEM. V. 55 3452 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22376051 JRNL DOI 10.1021/JM300126X REMARK 2 REMARK 2 RESOLUTION. 3.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 16557 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 825 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.23 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1117 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.73 REMARK 3 BIN R VALUE (WORKING SET) : 0.2850 REMARK 3 BIN FREE R VALUE SET COUNT : 49 REMARK 3 BIN FREE R VALUE : 0.3230 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4153 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 41 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.38000 REMARK 3 B22 (A**2) : -0.38000 REMARK 3 B33 (A**2) : 0.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.409 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.307 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 39.690 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.889 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4328 ; 0.008 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2937 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5855 ; 1.132 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7162 ; 0.783 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 516 ; 5.915 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 187 ;36.786 ;23.797 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 778 ;18.536 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 27 ;17.987 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 639 ; 0.175 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4714 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 846 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2582 ; 0.233 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1052 ; 0.030 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4174 ; 0.454 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1746 ; 0.615 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1669 ; 1.097 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 447 A 532 REMARK 3 ORIGIN FOR THE GROUP (A): 48.6400 -31.1396 13.8098 REMARK 3 T TENSOR REMARK 3 T11: 0.2400 T22: 0.2292 REMARK 3 T33: 0.3003 T12: 0.0489 REMARK 3 T13: -0.0090 T23: 0.0234 REMARK 3 L TENSOR REMARK 3 L11: 4.1466 L22: 4.3038 REMARK 3 L33: 7.8830 L12: -0.2405 REMARK 3 L13: 0.5870 L23: 0.8040 REMARK 3 S TENSOR REMARK 3 S11: 0.0473 S12: -0.6054 S13: -0.0451 REMARK 3 S21: 0.6409 S22: 0.0544 S23: -0.8751 REMARK 3 S31: 0.3730 S32: 0.9198 S33: -0.1017 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 533 A 720 REMARK 3 RESIDUE RANGE : A 901 A 901 REMARK 3 ORIGIN FOR THE GROUP (A): 43.5362 -43.6015 -9.0645 REMARK 3 T TENSOR REMARK 3 T11: 0.1870 T22: 0.1855 REMARK 3 T33: 0.1162 T12: -0.0034 REMARK 3 T13: 0.0590 T23: -0.0343 REMARK 3 L TENSOR REMARK 3 L11: 1.1130 L22: 5.4529 REMARK 3 L33: 3.1062 L12: -1.5605 REMARK 3 L13: -1.6198 L23: 1.5187 REMARK 3 S TENSOR REMARK 3 S11: 0.1515 S12: 0.1999 S13: 0.0106 REMARK 3 S21: -0.3553 S22: -0.0425 S23: -0.0160 REMARK 3 S31: -0.2285 S32: -0.0700 S33: -0.1090 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 447 B 532 REMARK 3 ORIGIN FOR THE GROUP (A): 36.1387 -12.8069 -2.5515 REMARK 3 T TENSOR REMARK 3 T11: 0.3038 T22: 0.1154 REMARK 3 T33: 0.2615 T12: 0.0849 REMARK 3 T13: 0.0612 T23: 0.0671 REMARK 3 L TENSOR REMARK 3 L11: 1.8879 L22: 4.4742 REMARK 3 L33: 8.6581 L12: 0.0101 REMARK 3 L13: -0.5599 L23: -0.5108 REMARK 3 S TENSOR REMARK 3 S11: 0.0406 S12: 0.3361 S13: 0.5317 REMARK 3 S21: -0.6904 S22: -0.1072 S23: -0.1516 REMARK 3 S31: -0.6861 S32: -0.1393 S33: 0.0666 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 533 B 719 REMARK 3 RESIDUE RANGE : B 901 B 901 REMARK 3 ORIGIN FOR THE GROUP (A): 20.7864 -15.6041 18.5082 REMARK 3 T TENSOR REMARK 3 T11: 0.0792 T22: 0.0694 REMARK 3 T33: 0.0826 T12: -0.0254 REMARK 3 T13: 0.0309 T23: 0.0273 REMARK 3 L TENSOR REMARK 3 L11: 5.3059 L22: 3.0649 REMARK 3 L33: 2.5667 L12: -2.1218 REMARK 3 L13: -2.1056 L23: 2.0615 REMARK 3 S TENSOR REMARK 3 S11: 0.0378 S12: 0.1987 S13: -0.1066 REMARK 3 S21: 0.0794 S22: -0.0060 S23: 0.1859 REMARK 3 S31: -0.0022 S32: -0.1282 S33: -0.0319 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES: WITH TLS ADDED REMARK 4 REMARK 4 4DBN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JAN-12. REMARK 100 THE DEPOSITION ID IS D_1000070127. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-09 REMARK 200 TEMPERATURE (KELVIN) : 92 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL CRYO-COOLED SI REMARK 200 (111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16557 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.150 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.87 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 9.6% PEG 8000, 0.8M LICL, 100 MM TRIS, REMARK 280 PH 8.3, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 73.42200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 55.52000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 55.52000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 36.71100 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 55.52000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 55.52000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 110.13300 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 55.52000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.52000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 36.71100 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 55.52000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.52000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 110.13300 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 73.42200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 442 REMARK 465 SER A 443 REMARK 465 ASP A 444 REMARK 465 SER A 445 REMARK 465 SER A 446 REMARK 465 ALA A 597 REMARK 465 THR A 598 REMARK 465 VAL A 599 REMARK 465 LYS A 600 REMARK 465 SER A 601 REMARK 465 ARG A 602 REMARK 465 TRP A 603 REMARK 465 SER A 604 REMARK 465 GLY A 605 REMARK 465 SER A 606 REMARK 465 HIS A 607 REMARK 465 GLN A 608 REMARK 465 PHE A 609 REMARK 465 GLU A 610 REMARK 465 GLN A 611 REMARK 465 LEU A 612 REMARK 465 SER A 613 REMARK 465 PRO A 721 REMARK 465 LYS A 722 REMARK 465 ILE A 723 REMARK 465 HIS A 724 REMARK 465 ARG A 725 REMARK 465 GLY B 442 REMARK 465 SER B 443 REMARK 465 ASP B 444 REMARK 465 SER B 445 REMARK 465 SER B 446 REMARK 465 SER B 604 REMARK 465 GLY B 605 REMARK 465 SER B 606 REMARK 465 HIS B 607 REMARK 465 GLN B 608 REMARK 465 PHE B 609 REMARK 465 GLU B 610 REMARK 465 GLN B 611 REMARK 465 LEU B 612 REMARK 465 SER B 613 REMARK 465 LEU B 720 REMARK 465 PRO B 721 REMARK 465 LYS B 722 REMARK 465 ILE B 723 REMARK 465 HIS B 724 REMARK 465 ARG B 725 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 467 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 521 CG CD CE NZ REMARK 470 LYS B 521 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 452 156.18 -47.16 REMARK 500 SER A 466 -30.65 80.57 REMARK 500 PHE A 467 38.18 -89.46 REMARK 500 PRO A 522 -70.20 -111.82 REMARK 500 ILE A 542 -66.52 -98.12 REMARK 500 ARG A 574 -4.01 78.16 REMARK 500 ASP A 575 47.31 -163.13 REMARK 500 ASP A 586 18.09 50.21 REMARK 500 LEU A 587 -47.64 -134.34 REMARK 500 MET A 626 67.15 29.46 REMARK 500 GLN A 627 -77.11 -58.16 REMARK 500 GLN B 460 174.18 -54.27 REMARK 500 ILE B 542 -63.39 -107.32 REMARK 500 LYS B 546 68.60 -119.74 REMARK 500 ARG B 574 -15.10 81.42 REMARK 500 ASP B 575 45.17 -144.93 REMARK 500 LEU B 587 81.78 -156.86 REMARK 500 THR B 588 104.81 155.76 REMARK 500 ALA B 717 21.71 -67.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0JA A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0JA B 901 DBREF 4DBN A 444 725 UNP P15056 BRAF_HUMAN 445 726 DBREF 4DBN B 444 725 UNP P15056 BRAF_HUMAN 445 726 SEQADV 4DBN GLY A 442 UNP P15056 EXPRESSION TAG SEQADV 4DBN SER A 443 UNP P15056 EXPRESSION TAG SEQADV 4DBN GLY B 442 UNP P15056 EXPRESSION TAG SEQADV 4DBN SER B 443 UNP P15056 EXPRESSION TAG SEQRES 1 A 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 A 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 A 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 A 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 A 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 A 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 A 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 A 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 A 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 A 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 A 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 A 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 A 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 A 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 A 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 A 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 A 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 A 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 A 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 A 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 A 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 A 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG SEQRES 1 B 284 GLY SER ASP SER SER ASP ASP TRP GLU ILE PRO ASP GLY SEQRES 2 B 284 GLN ILE THR VAL GLY GLN ARG ILE GLY SER GLY SER PHE SEQRES 3 B 284 GLY THR VAL TYR LYS GLY LYS TRP HIS GLY ASP VAL ALA SEQRES 4 B 284 VAL LYS MET LEU ASN VAL THR ALA PRO THR PRO GLN GLN SEQRES 5 B 284 LEU GLN ALA PHE LYS ASN GLU VAL GLY VAL LEU ARG LYS SEQRES 6 B 284 THR ARG HIS VAL ASN ILE LEU LEU PHE MET GLY TYR SER SEQRES 7 B 284 THR LYS PRO GLN LEU ALA ILE VAL THR GLN TRP CYS GLU SEQRES 8 B 284 GLY SER SER LEU TYR HIS HIS LEU HIS ILE ILE GLU THR SEQRES 9 B 284 LYS PHE GLU MET ILE LYS LEU ILE ASP ILE ALA ARG GLN SEQRES 10 B 284 THR ALA GLN GLY MET ASP TYR LEU HIS ALA LYS SER ILE SEQRES 11 B 284 ILE HIS ARG ASP LEU LYS SER ASN ASN ILE PHE LEU HIS SEQRES 12 B 284 GLU ASP LEU THR VAL LYS ILE GLY ASP PHE GLY LEU ALA SEQRES 13 B 284 THR VAL LYS SER ARG TRP SER GLY SER HIS GLN PHE GLU SEQRES 14 B 284 GLN LEU SER GLY SER ILE LEU TRP MET ALA PRO GLU VAL SEQRES 15 B 284 ILE ARG MET GLN ASP LYS ASN PRO TYR SER PHE GLN SER SEQRES 16 B 284 ASP VAL TYR ALA PHE GLY ILE VAL LEU TYR GLU LEU MET SEQRES 17 B 284 THR GLY GLN LEU PRO TYR SER ASN ILE ASN ASN ARG ASP SEQRES 18 B 284 GLN ILE ILE PHE MET VAL GLY ARG GLY TYR LEU SER PRO SEQRES 19 B 284 ASP LEU SER LYS VAL ARG SER ASN CYS PRO LYS ALA MET SEQRES 20 B 284 LYS ARG LEU MET ALA GLU CYS LEU LYS LYS LYS ARG ASP SEQRES 21 B 284 GLU ARG PRO LEU PHE PRO GLN ILE LEU ALA SER ILE GLU SEQRES 22 B 284 LEU LEU ALA ARG SER LEU PRO LYS ILE HIS ARG HET 0JA A 901 38 HET 0JA B 901 38 HETNAM 0JA 2-CHLORO-3-(1-CYANOCYCLOPROPYL)-N-[5-({2- HETNAM 2 0JA [(CYCLOPROPYLCARBONYL)AMINO][1,3]THIAZOLO[5,4- HETNAM 3 0JA B]PYRIDIN-5-YL}OXY)-2-FLUOROPHENYL]BENZAMIDE FORMUL 3 0JA 2(C27 H19 CL F N5 O3 S) FORMUL 5 HOH *41(H2 O) HELIX 1 1 THR A 490 ARG A 505 1 16 HELIX 2 2 LEU A 536 ILE A 542 1 7 HELIX 3 3 GLU A 548 LYS A 569 1 22 HELIX 4 4 SER A 615 MET A 619 5 5 HELIX 5 5 ALA A 620 ARG A 625 1 6 HELIX 6 6 SER A 633 GLY A 651 1 19 HELIX 7 7 ASN A 660 GLY A 671 1 12 HELIX 8 8 ASP A 676 VAL A 680 5 5 HELIX 9 9 PRO A 685 LEU A 696 1 12 HELIX 10 10 LYS A 699 ARG A 703 5 5 HELIX 11 11 LEU A 705 SER A 719 1 15 HELIX 12 12 THR B 490 ARG B 505 1 16 HELIX 13 13 SER B 535 ILE B 542 1 8 HELIX 14 14 GLU B 548 LYS B 569 1 22 HELIX 15 15 LYS B 577 ASN B 579 5 3 HELIX 16 16 GLU B 585 LEU B 587 5 3 HELIX 17 17 SER B 615 MET B 619 5 5 HELIX 18 18 ALA B 620 MET B 626 1 7 HELIX 19 19 SER B 633 GLY B 651 1 19 HELIX 20 20 ASN B 660 ARG B 670 1 11 HELIX 21 21 ASP B 676 VAL B 680 5 5 HELIX 22 22 PRO B 685 LEU B 696 1 12 HELIX 23 23 LYS B 699 ARG B 703 5 5 HELIX 24 24 LEU B 705 ALA B 717 1 13 SHEET 1 A 5 THR A 457 SER A 464 0 SHEET 2 A 5 THR A 469 LYS A 474 -1 O LYS A 472 N GLN A 460 SHEET 3 A 5 ASP A 478 MET A 483 -1 O MET A 483 N THR A 469 SHEET 4 A 5 ALA A 525 GLN A 529 -1 O ILE A 526 N LYS A 482 SHEET 5 A 5 PHE A 515 SER A 519 -1 N GLY A 517 O VAL A 527 SHEET 1 B 3 GLY A 533 SER A 535 0 SHEET 2 B 3 ILE A 581 HIS A 584 -1 O LEU A 583 N SER A 534 SHEET 3 B 3 THR A 588 ILE A 591 -1 O LYS A 590 N PHE A 582 SHEET 1 C 5 THR B 457 ARG B 461 0 SHEET 2 C 5 THR B 469 LYS B 474 -1 O LYS B 474 N THR B 457 SHEET 3 C 5 ASP B 478 MET B 483 -1 O VAL B 479 N GLY B 473 SHEET 4 C 5 ALA B 525 GLN B 529 -1 O THR B 528 N ALA B 480 SHEET 5 C 5 PHE B 515 SER B 519 -1 N GLY B 517 O VAL B 527 SHEET 1 D 2 ILE B 581 LEU B 583 0 SHEET 2 D 2 VAL B 589 ILE B 591 -1 O LYS B 590 N PHE B 582 SITE 1 AC1 17 ALA A 480 LYS A 482 GLU A 500 LEU A 504 SITE 2 AC1 17 THR A 507 LEU A 513 ILE A 526 THR A 528 SITE 3 AC1 17 GLN A 529 TRP A 530 CYS A 531 GLY A 533 SITE 4 AC1 17 PHE A 582 GLY A 592 ASP A 593 PHE A 594 SITE 5 AC1 17 HOH A1002 SITE 1 AC2 15 ALA B 480 LYS B 482 GLU B 500 VAL B 503 SITE 2 AC2 15 LEU B 504 ILE B 526 THR B 528 GLN B 529 SITE 3 AC2 15 TRP B 530 CYS B 531 PHE B 582 GLY B 592 SITE 4 AC2 15 ASP B 593 PHE B 594 ALA B 597 CRYST1 111.040 111.040 146.844 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009006 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009006 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006810 0.00000